NEW YORK (GenomeWeb News) – Poland's University of Lodz will use Cellectricon's cell-based screening system in its genomic research programs, the company said today.
Under the agreement, the university will use the Cellaxess HT system for high-throughput transfection, which the company said enables the delivery of any genetic material to cells without the use of reagents.
The university bought the Cellaxess system with funding from Poland's Innovative Economy Operational Program, which is supported in part by the EU's European Regional Development Fund.
Grzegorz Bartosz, who heads the school's Department of Molecular Biophysics, said in a statement that there is a significant need "for a technology enabling high transfection efficiency and viability in biologically relevant cell types."
The Cellectricon system "will allow us to undertake ambitious expression and silencing screening projects that would have been both economically and practically unfeasible with conventional instrumentation," he continued.